Press "Enter" to skip to content

Lupin gets USFDA nod to market its cholesterol lowering drug

Drug firm Lupin Thursday said it has received nod from the US health regulator to market its generic Atorvastatin Calcium tablets, used for lowering cholesterol, in the American market.

Original source:

Also Read:   Sikkim drug manufacturing units halt operations due to Covid, raising supply concerns